Pancreatic Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have been diagnosed with pancreatic ductal adenocarcinoma (a specific type of pancreatic cancer), confirmed by a tissue or cell sample.
- You are planned to start a first-line chemotherapy treatment called FOLFIRINOX (meaning you have not yet had chemotherapy for your current stage of disease).
- You are 18 years of age or older.
- You are generally well enough to carry out daily activities with little or no limitation, as assessed by your doctor.
- Your blood counts and organ function (including bone marrow, kidneys, and liver) meet certain healthy levels as measured by blood tests (confirm with trial site for specific values).
- Your potassium levels are within a normal range, or can be brought into range with supplements.
- Your blood clotting levels are within an acceptable range.
- You are able to understand the study information and sign a consent form agreeing to take part.
- You are able to attend study visits and follow the study requirements.
- You are able to swallow tablets/capsules and can receive injections under the skin without any medical reason preventing this.
- Your cancer can be measured or assessed using standard medical imaging at the start of the study.
- Your doctor estimates you have a life expectancy of more than 90 days.
Who may not be able to join:
- Your cancer has not spread to distant parts of the body or lymph nodes (the trial is not for borderline resectable or locally advanced disease).
- You have previously received chemotherapy or other anti-cancer treatments specifically for metastatic (spread) pancreatic cancer (though prior chemotherapy after surgery for early-stage disease is allowed).
- You are currently receiving any chemotherapy or other anti-cancer treatment.
- Your doctor feels you are not well enough to safely receive combination chemotherapy.
- Your cancer has spread to the brain.
- You have a known diagnosis of Type 1 diabetes.
- You have a known diagnosis of Type 2 diabetes and are already being seen by a diabetes specialist (endocrinologist).
- You are pregnant (confirmed by a positive pregnancy test).
- Your doctor believes it would not be safe for you to join the study, for any medical or non-medical reason.
- You are unable to attend study assessments and follow-up appointments.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Daniel Renouf, MD, MPH, BC Cancer
Phone: 800-663-3333
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Frequency of glucose levels maintained within range in Arm 1 compared to Arm 2
Can't join this trial?
Data last synced from ClinicalTrials.gov: 5 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.